ASND NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Ascendis Pharma AS · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 243.9 USD
-3.9% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 4.4% above the Trend Line and sits at 64.9% of its 52-week range. The latest completed week returned -3.9%, after a -11.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bearish with 44/100 conviction, while the latest news-sentiment score is 58/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 49 out of 100
Latest Close 243.9 USD 31 Jul 2026
1W Return -3.9% latest completed week
4W Return -11.1% short-term follow-through
12W Return 2.2% quarterly tape
Trend Breadth 96.2% 50 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 6-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 13 reversal markers appear in the recent smart-money tape.
  • Latest weekly return ranks in the weaker part of its sector group.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -3.9% Latest completed week; four-week move -11.1%. Indicator stack 74/79 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bearish 44/100 conviction; expected move 11.0%. News sentiment 58/100 66 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 4.4% above the Trend Line and sits at 64.9% of its 52-week range. The latest completed week returned -3.9%, after a -11.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6712-week average 0.62

12-week confirmation

Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.67Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1313 reversal markers

No recent accumulation markers. 13 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -11.1% over four weeks, 2.2% over 12 weeks, and 39.8% over one year. The current trend has remained active for 6 consecutive weeks.

Performance by holding period

1W-3.9%
4W-11.1%
12W2.2%
26W7.9%
52W39.8%
Active trend streak6 weeks
Active weeks in one year50
Trend breadth96.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.48Latest activity-pressure read.
Pressure change250.8%Four-week change in activity pressure.
Leadership1.33Latest relative-leadership reading.
RS change-88.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 02 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 91% Model confidence 86%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength14/100Blend of value, momentum, and quality. Underlying universe rank 87; rank 1 is best.
Value4/100Relative valuation strength. Underlying universe rank 97; rank 1 is best.
Quality27/100Profitability and accounting quality. Underlying universe rank 74; rank 1 is best.
Momentum88/100Medium-term price momentum. Underlying universe rank 13; rank 1 is best.
Growth89/100Revenue and earnings growth. Underlying universe rank 12; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
31.6x
Price divided by trailing earnings.
Price / sales
18.4x
Market value relative to trailing revenue.
EV / EBITDA
1319.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
0.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
88.2%
Gross profit retained from each unit of revenue.
Operating margin
-0.6%
Operating profit retained from revenue.
Free-cash-flow margin
8.4%
Free cash flow generated from revenue.
Return on invested capital
-0.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
135.3%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.3%
Net share repurchases relative to market value.
Shareholder yield
0.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
26.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

ASND shows bearish options pressure with a 44/100 conviction score, put-call volume ratio of 1.91, expected move of 11.0%, and Sharemaestro trend signal active.

Conviction44/100
Expected move11.0%
Put/call volume1.91
Pressure-23
Speculation16
Volatility81
Trend agreement86
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment58/100

Weighted news tone is neutral across 66 relevant articles.

22 positive · 41 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move11.0%Nearest-chain priced movement where available.
52-week drawdown-13.6%Distance below the 52-week high.
13-week volatility6.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+13.0%Week of 26 Jun.
Worst week-9.3%Week of 29 May.
Latest week-3.9%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains6
Flat weeks0
Modest losses9
Sharp losses4
Recent vol6.0%13-week weekly-return volatility.
Base vol5.1%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew4.6% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape55/100

Trend, activity pressure, participation, and risk combine to a 55/100 tape read.

 Indicator analysis53/100

Latest 12-week confirmation: trend 10/12, activity pressure 5/12, relative leadership 7/12.

Activity pressure 0.67; 13 reversal markers Factors30/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 37; Small Cap Core rank 99 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options53/100

ASND shows bearish options pressure with a 44/100 conviction score, put-call volume ratio of 1.91, expected move of 11.0%, and Sharemaestro trend signal active.

Bearish · Put-side pressure · Expected move 11.0% Sentiment58/100

Weighted news tone is neutral across 66 relevant articles.

ASND News & Events Insiders50/100

No recent insider transaction evidence is stored.

 Earnings3d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.

 Research flow2 items

1 recent research articles and 1 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026243.9 USD-3.9%233.7 USD163.4 USD0.481.332.4MOn
24 Jul 2026253.9 USD-2.7%232.6 USD162.4 USD0.726.272.2MOn
17 Jul 2026261.0 USD-3.5%231.2 USD161.4 USD0.917.962.7MOn
10 Jul 2026270.4 USD-1.5%229.1 USD160.3 USD0.647.643.0MOn
3 Jul 2026274.5 USD5.3%227.5 USD159.1 USD0.1411.572.8MOn
26 Jun 2026260.8 USD13.0%225.1 USD157.9 USD-0.437.329.0MOn
19 Jun 2026230.8 USD5.9%223.5 USD156.8 USD-0.96-8.993.1MOff
12 Jun 2026218.1 USD3.6%222.9 USD155.9 USD-0.72-11.863.1MOff
5 Jun 2026210.4 USD-6.1%222.4 USD155.1 USD-0.48-13.082.7MOn
29 May 2026224.1 USD-9.3%222.0 USD154.4 USD-0.19-11.751.3MOn
22 May 2026247.1 USD2.7%221.2 USD153.5 USD-0.090.032.4MOn
15 May 2026240.5 USD0.8%219.7 USD152.5 USD-0.16-1.302.7MOn
8 May 2026238.7 USD8.0%218.7 USD151.5 USD0.10-2.173.8MOn
1 May 2026220.9 USD-3.6%217.8 USD150.6 USD0.25-4.335.6MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.